28 March 2018 15:00 BST
TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
Disclosure under Article 19 of the EU Market Abuse Regulation
AstraZeneca PLC (the Company) announces that, on 27 March 2018, awards of the Company's ordinary shares of $0.25 each (Ordinary Shares) vested to certain Persons Discharging Managerial Responsibilities of the Company (PDMRs) under the AstraZeneca Deferred Bonus Plan (AZDBP).
The AZDBP award was granted on 27 March 2015, following the deferral of a portion of each PDMR's annual bonus paid in respect of 2014 performance into Ordinary Shares, and vested on completion of the three-year holding period.
Following the withholding of shares to satisfy certain tax obligations arising on vesting, the PDMRs' beneficial interests in Ordinary Shares changed as detailed in the table below:
|PDMR||Ordinary Shares acquired under the AZDBP|
For tax purposes, the fair market value of an Ordinary Share at vest was 4760.0 pence, being the closing price on the last trading day preceding the vesting day.
Further details are set out in the attached notifications, made in accordance with the requirements of the EU Market Abuse Regulation.
Please click on the PDF document below to view the full announcement:
This information is provided by RNS
The company news service from the London Stock Exchange